Clinical Laboratory Improvement Advisory Committee; Notice of Charter Renewal

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

March 8, 2024

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the renewal of the charter of the Clinical Laboratory Improvement Advisory Committee (CLIAC).

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 47 (Friday, March 8, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 47 (Friday, March 8, 2024)]
[Notices]
[Page 16773]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-04962]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee; Notice of 
Charter Renewal

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of charter renewal.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), within 
the Department of Health and Human Services (HHS), announces the 
renewal of the charter of the Clinical Laboratory Improvement Advisory 
Committee (CLIAC).

FOR FURTHER INFORMATION CONTACT: Reynolds M. Salerno, Ph.D., Designated 
Federal Officer, Clinical Laboratory Improvement Advisory Committee, 
Centers for Disease Control and Prevention, Department of Health and 
Human Services, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia 
30329-4027. Telephone: (404) 498-6516; Email: <a href="/cdn-cgi/l/email-protection#a8fafbc9c4cddac6c7e8cbcccb86cfc7de"><span class="__cf_email__" data-cfemail="91c3c2f0fdf4e3fffed1f2f5f2bff6fee7">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: CDC is providing notice under 5 U.S.C. 1001-
1014 of the renewal of the charter of the Clinical Laboratory 
Improvement Advisory Committee, Centers for Disease Control and 
Prevention, Department of Health and Human Services. This charter has 
been renewed for a two-year period through February 19, 2026.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04962 Filed 3-7-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on March 8, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.